These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21481331)

  • 21. Sunitinib adverse event: oral bullous and lichenoid mucositis.
    Mignogna MD; Fortuna G; Leuci S; Pollio A; Ruoppo E
    Ann Pharmacother; 2009 Mar; 43(3):546-7. PubMed ID: 19240256
    [No Abstract]   [Full Text] [Related]  

  • 22. Propafenone-induced acute generalized exanthematous pustulosis.
    Huang YM; Lee WR; Hu CH; Cheng KL
    Int J Dermatol; 2005 Mar; 44(3):256-7. PubMed ID: 15807741
    [No Abstract]   [Full Text] [Related]  

  • 23. Lung toxicity in a patient treated with sunitinib.
    Boyle HJ; Chatté G; Rivoire M; Fléchon A
    Eur Respir J; 2012 Nov; 40(5):1300-3. PubMed ID: 23115316
    [No Abstract]   [Full Text] [Related]  

  • 24. Case of sunitinib-induced Stevens-Johnson syndrome.
    Lee JH; Lee JH; Lee JH; Kim SY; Kim GM
    J Dermatol; 2013 Sep; 40(9):753-4. PubMed ID: 23855706
    [No Abstract]   [Full Text] [Related]  

  • 25. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
    Al Enazi MM; Kadry R; Mitwali H
    J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of bromoderma and bromism.
    Hafiji J; Majmudar V; Mathews S; Green A; Rytina E; Burrows NP
    Br J Dermatol; 2008 Feb; 158(2):427-9. PubMed ID: 18047506
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute severe hypothyroidism induced by sunitinib.
    Prat A; Serrano C; Valverde C; Calvo E
    Radiother Oncol; 2008 Oct; 89(1):124-5. PubMed ID: 18502526
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hand-foot syndrome after administration of tyrosinkinase inhibitors].
    Bednaríková D; Kocák I
    Klin Onkol; 2010; 23(5):300-5. PubMed ID: 21061680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrocytosis due to treatment with sunitinib.
    Billemont B; Izzedine H; Rixe O
    N Engl J Med; 2007 Sep; 357(13):1351-2; author reply 1352. PubMed ID: 17898111
    [No Abstract]   [Full Text] [Related]  

  • 30. [Generalized pruritic eruption during terbinafine treatment].
    Amouri M; El Euch D; El Ouni B; Daoued O; Ouselati MH; Ferjani M; Dhahri AB
    Presse Med; 2008 Dec; 37(12):1836-40. PubMed ID: 18656325
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib: a critical review and meta analysis.
    Abdel-Rahman O; Fouad M
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):129-41. PubMed ID: 25482593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eccrine squamous syringometaplasia associated with sunitinib therapy.
    Sheen YS; Huang CL; Chu CY
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1136-7. PubMed ID: 17714156
    [No Abstract]   [Full Text] [Related]  

  • 33. Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
    Ohtsuka T
    J Dermatol; 2012 Nov; 39(11):943-4. PubMed ID: 22257303
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac toxicity of sunitinib.
    Joensuu H
    Lancet; 2007 Dec; 370(9604):1978-80. PubMed ID: 18083385
    [No Abstract]   [Full Text] [Related]  

  • 35. Sunitinib-aggravated hypertension.
    Rivera F; Benounna M; Sánchez de la Nieta MD
    J Hypertens; 2009 Jul; 27(7):1502-3. PubMed ID: 19542988
    [No Abstract]   [Full Text] [Related]  

  • 36. Sunitinib and Thrombosis.
    Lamba G; Deol R; Shah D; Sahni R; Malhotra BK
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S128-30. PubMed ID: 21881834
    [No Abstract]   [Full Text] [Related]  

  • 37. Sunitinib-induced hemoglobin changes are related to the dosing schedule.
    van der Veldt AA; Boven E; Vroling L; Broxterman HJ; van den Eertwegh AJ; Haanen JG
    J Clin Oncol; 2009 Mar; 27(8):1339-40; author reply 1340-2. PubMed ID: 19188672
    [No Abstract]   [Full Text] [Related]  

  • 38. Unanswered questions regarding the management of sunitinib-induced hypothyroidism.
    Garfield D; Hercbergs A; Davis P
    Nat Clin Pract Oncol; 2007 Dec; 4(12):674. PubMed ID: 17955044
    [No Abstract]   [Full Text] [Related]  

  • 39. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
    ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
    Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
    [No Abstract]   [Full Text] [Related]  

  • 40. The appearance of inflammatory papules in the skin surrounding areas treated with imiquimod cream for basal cell carcinoma.
    Stinco G; Frattasio A; Forcione M; Quinkenstein E; Finato N; Patrone P
    Br J Dermatol; 2008 Feb; 158(2):408-9. PubMed ID: 18028501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.